Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty / Anne M. Kenny, Alison Kleppinger, Kristen Annis, Margaret Rathier, Bruce Browner, James O. Judge, Daniel McGee. - (Journal of the American Geriatrics Society 58 (2010) 6 (June); p. 1134-1143)

  • PMID: 20722847
  • PMCID: PMC3014265
  • DOI: 10.1111/j.1532-5415.2010.02865.x


Abstract

Objectives: To investigate the effects of testosterone supplementation on bone, body composition, muscle, physical function, and safety in older men.

Design: Double-blind, randomized, placebo-controlled trial.

Setting: A major medical institution.

Participants: One hundred thirty-one men (mean age 77.1 +/- 7.6) with low testosterone, history of fracture, or bone mineral density (BMD) T-score less than -2.0 and frailty.

Intervention: Participants received 5 mg/d of testosterone or placebo for 12 to 24 months; all received calcium (1500 mg/d diet and supplement) and cholecalciferol (1,000 IU/d).

Measurements: BMD of hip, lumbar spine, and mid-radius; body composition; sex hormones, calcium-regulating hormones; bone turnover markers; strength; physical performance; and safety parameters.

Results: Ninety-nine men (75.6%) completed 12 months, and 62 (47.3%) completed end therapy (mean 23 months; range 16-24 months for 62 who completed therapy). Study adherence was 54%, with 40% of subjects maintaining 70% or greater adherence. Testosterone and bioavailable testosterone levels at 12 months were 583 ng/dL and 157 ng/dL, respectively, in the treatment group. BMD on testosterone increased 1.4% at the femoral neck and 3.2% at the lumbar spine (P=.005) and decreased 1.3% at the mid-radius (P<.001). There was an increase in lean mass and a decrease in fat mass in the testosterone group but no differences in strength or physical performance. There were no differences in safety parameters.

Conclusion: Older, frail men receiving testosterone replacement increased testosterone levels and had favorable changes in body composition, modest changes in axial BMD, and no substantial changes in physical function.

Original document

Parameters

Science
Study
Date
1 June 2010
People
Annis, Kristen
Browner, Bruce
Judge, James O.
Kenny, Anne M.
Kleppinger, Alison
McGee, Daniel
Rathier, Margaret
Country
United States of America
Language
English
Other organisations
University of Connecticut Health Center (UConn Health)
Doping classes
S1. Anabolic Agents
Substances
Testosterone
Medical terms
Health effects
Legitimate Medical Treatment
Document category
Scientific article
Document type
Pdf file
Date generated
29 October 2020
Date of last modification
30 October 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin